Sign In
Media & Investors
Skip Navigation LinksSanten > EMEA > Media & Investors > Investors

Santen Pharmaceutical welcomes your inquiries and opinions.


Basic data concerning our stocks, stock-handling procedures, stock price trends, and materials for general meetings of shareholders can be found from:​

Overview on Santen

​Name​Santen Pharmaceutical Co. Ltd.
​Corporate Headquater

​Grand Front Osaka Tower A,
4-20 Ofuka-cho, Kita-ku, Osaka 530-8552, Japan
(Reception desk is on the 25th Floor.)


TEL: +81-6-6321-7000
FAX: +81-6-6321-5082

Paid-in Capital​7,383 million yen (As of Mar 31, 2015)
Number of Employees​3,230 (Consolidated) (As of Mar 31, 2015)
​​Representatives​Akira Kurokawa (President & CEO)
​Stock Exchange Listings​Tokyo (Stock code: 4536)
​Business​Research and development, production and marketing of pharmaceuticals and medical devices
​Offices, Laboratories & Plants

Nara Research and Development Center, Noto Plant, Shiga Product Supply Center, 98 offices in Japan, Beijing Representative Office and Ho Chi Minh Representative Office


Japan: Claire Co., Ltd., etc.
International: Santen Inc. (US), Santen Oy (Finland), etc.